Pathologic upstaging and survival outcomes for patients undergoing segmentectomy versus lobectomy in clinical stage T1cN0M0 non–small cell lung cancerCentral MessagePerspective by Ryan C. Jacobs, MD, MS, Erik E. Rabin, MD, Charles D. Logan, MD, Sandeep N. Bharadwaj, MD, Hee Chul Yang, MD, Raheem D. Bell, MD, Emily J. Cerier, MD, Chitaru Kurihara, MD, Kalvin C. Lung, MD, Diego M. Avella Patino, MD, Samuel S. Kim, MD, Ankit Bharat, MBBS

Get full text